HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)

Clinical trials for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) explained in plain language.

Never miss a new study

Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) trials appear

Sign up with your email to follow new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

Can a cholesterol drug prevent heart attacks in rare genetic disorder?

Disease control Ongoing

This study aims to see if the drug lomitapide reduces major heart-related events like heart attacks and strokes in people with a rare, severe form of genetic high cholesterol (HoFH). It will compare the number of these events in 73 patients during their first three years on the d…

Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH)

Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH) trials appear

Can a cholesterol drug prevent heart attacks in rare genetic disorder?